Pancreatic Cancer Research

ResearcherTUM KlinikumNo recent work listed

Peter Büchler

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5087750803. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study. First author DOI 10.1097/ms9.0000000000000854↗
  2. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer. Last author DOI 10.1002/cncr.26344↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giulia Manzini · 1 shared paper, 2023 · strength 0.26
  2. Katrin Bauer · 1 shared paper, 2023 · strength 0.26
  3. Helmut Frieß · 1 shared paper, 2012 · strength 0.03
  4. Markus Wolfgang Büchler · 1 shared paper, 2012 · strength 0.03
  5. Martin Loos · 1 shared paper, 2012 · strength 0.03
  6. Yun Yan Su · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.